Contract Research & Services
Contract Services

Heightened FDA Enforcement for Sterility Issuesin Pharma Biotech with NSF

Published 13 June 2017 | By NSF International

NSF analysed all of the warning letters issued to pharma and biologic manufacturers for sterility issues since 2015. This white paper provides detailed insight into our analysis. It includes relative charts and a table with a summary of the regulations cited by the FDA as well as recommendations for closing your compliance gaps.

Available Downloads

Heightened FDA Enforcement for Sterility Issuesin Pharma Biotech with NSF